UBS’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$510K Sell
11,978
-1,682
-12% -$71.6K ﹤0.01% 3160
2014
Q2
$845K Sell
13,660
-1,711
-11% -$106K ﹤0.01% 2814
2014
Q1
$999K Buy
15,371
+1,691
+12% +$110K ﹤0.01% 2642
2013
Q4
$770K Buy
13,680
+1,475
+12% +$83K ﹤0.01% 2781
2013
Q3
$748K Sell
12,205
-563
-4% -$34.5K ﹤0.01% 2671
2013
Q2
$746K Buy
+12,768
New +$746K ﹤0.01% 2598